Residency · Indianapolis, IN
Sponsored by Indiana University School of Medicine
Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer.
The New England journal of medicine · 2021 · 2,264 citations · Chandler Park
The TRIPOD-LLM reporting guideline for studies using large language models.
Nature medicine · 2025 · 345 citations · Judy Gichoya
Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2022 · 1,201 citations · David Spigel
Assessing the potential of GPT-4 to perpetuate racial and gender biases in health care: a model evaluation study.
The Lancet. Digital health · 2024 · 332 citations · Judy Gichoya
Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer.
The New England journal of medicine · 2022 · 840 citations · Chandler Park
First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial.
Lancet (London, England) · 2021 · 999 citations · Anne Tsao
Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer.
The New England journal of medicine · 2024 · 289 citations · David Spigel
ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile Infections.
The American journal of gastroenterology · 2021 · 458 citations · Monika Fischer